BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 20629475)

  • 1. Diagnosis and management of ductal carcinoma in situ (DCIS).
    Virnig BA; Shamliyan T; Tuttle TM; Kane RL; Wilt TJ
    Evid Rep Technol Assess (Full Rep); 2009 Sep; (185):1-549. PubMed ID: 20629475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(3):1-55. PubMed ID: 23074406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal Carcinoma In Situ - Quo Vadis?
    Peltecu G
    Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.
    Chuwa EW; Tan VH; Tan PH; Yong WS; Ho GH; Wong CY
    ANZ J Surg; 2008; 78(1-2):42-8. PubMed ID: 18199204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
    Fisher B; Land S; Mamounas E; Dignam J; Fisher ER; Wolmark N
    Semin Oncol; 2001 Aug; 28(4):400-18. PubMed ID: 11498833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.
    Kane RL; Virnig BA; Shamliyan T; Wang SY; Tuttle TM; Wilt TJ
    J Natl Cancer Inst Monogr; 2010; 2010(41):130-3. PubMed ID: 20956816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K
    Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Therapeutic Approaches to DCIS.
    Doke K; Butler S; Mitchell MP
    J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):279-291. PubMed ID: 30267199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current perspectives of treatment of ductal carcinoma in situ.
    Estévez LG; Alvarez I; Seguí MÁ; Muñoz M; Margelí M; Miró C; Rubio C; Lluch A; Tusquets I
    Cancer Treat Rev; 2010 Nov; 36(7):507-17. PubMed ID: 20462701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of 23,810 cases of ductal carcinoma-in-situ.
    Sumner WE; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D
    Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence map of ductal carcinoma in situ management options.
    Bouskill K; Hempel S; Richardson A; Ganz PA; Baxi S; Zutshi R; Larkin J; Motala A; Miles JNV; Crandall CJ
    Menopause; 2019 Nov; 26(11):1250-1258. PubMed ID: 31567868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
    Schmitz RSJM; van den Belt-Dusebout AW; Clements K; Ren Y; Cresta C; Timbres J; Liu YH; Byng D; Lynch T; Menegaz BA; Collyar D; Hyslop T; Thomas S; Love JK; Schaapveld M; Bhattacharjee P; Ryser MD; Sawyer E; Hwang ES; Thompson A; Wesseling J; Lips EH; Schmidt MK;
    BMJ; 2023 Oct; 383():e076022. PubMed ID: 37903527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.
    Mannu GS; Wang Z; Broggio J; Charman J; Cheung S; Kearins O; Dodwell D; Darby SC
    BMJ; 2020 May; 369():m1570. PubMed ID: 32461218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should low-risk DCIS lose the cancer label? An evidence review.
    Ma T; Semsarian CR; Barratt A; Parker L; Pathmanathan N; Nickel B; Bell KJL
    Breast Cancer Res Treat; 2023 Jun; 199(3):415-433. PubMed ID: 37074481
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.